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Abstract: It is essential to establish a pattern to detect the strengths and weaknesses of working
groups publishing on malaria, to promote coordination to facilitate the eradication of the disease.
Given the complexity of the scientific network of groups and institutions studying malaria, it is
necessary to use a mathematical algorithm that allows us to know the real structure of research on the
disease in the world. In this work, articles with the word “malaria” in the title or author keywords
gathered from Elsevier Scopus database were analyzed. By means of specific software, graphs were
created. The analysis of the data allowed established different scientific communities, among which
two were very diverse: one formed by those groups concerned about the vector transmission and
control, and another one focused on the drug resistance of the parasite. Basic, applied, and operational
research to eradicate malaria is an ambitious goal of the international institutions and the scientific
community. The combination of effort and the establishment of a worldwide-scientific network that
allows an effective interconnection (exchange) of knowledge, infrastructure technology, collaborators,
financial resources, and datasets will contribute more effectively to end the disease.
Keywords: malaria; vector; drug resistance; scientific community
1. Introduction
Malaria is one of the infectious diseases that generates the greatest concern to global health [1,2].
According to the last report of the World Health Organization, in 2016, malaria produced almost half a
million deaths and more than 200 million cases were estimated, with 90% of these cases occurring in
African countries. Malaria is a mosquito-borne disease caused by a parasite of the genus Plasmodium,
with six species that affect humans: Plasmodium falciparum, which causes the most deaths, Plasmodium
vivax, the most widely spread except in sub-Saharan Africa, Plasmodium malariae, Plasmodium knowlesi,
Plasmosdium ovale curtisi, and Plasmodium ovale wallikeri [3–6].
Plasmodium has a complex life cycle, developing partially in mosquitoes of the genus Anopheles [7].
In humans, the parasite has a multiplicative exoerythrocytic stage, in hepatic cells, and another
intraerythrocytic phase. The beginning of the cycle occurs with the bite of an infected female Anopheles
mosquito, which inoculates the sporozoites in the vertebrate host. These migrate to hepatic cells,
where they multiply and transform into exoerythrocytic merozoites that invade red blood cells again,
generating erythrocytic merozoites that can invade new red blood cells and generate a new batch of
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merozoites or developed into gametocytes. Gametocytes will be ingested when Anopheles females
bite the host to feed on their blood. In P. vivax and P. ovale, the hepatic schizont can remain dormant
harboring hypnozoites that can be reactivated years later.
The malaria parasite is also genetically complex [8]. However, the current molecular tools make
the analysis of genetic material available to produce data of great interest. The search for genes
associated with drug resistance or phenotypes related to clinical manifestations of high pathogenicity,
are two fundamental aspects addressed at a molecular level in malaria research. The nuclear genome
of P. falciparum was sequenced in 2002 [6], and, later, the complete genomes of the rest of the human
Plasmodium were obtained. These genomes have a size ranged from 23.3 to 33.6 Mb, organized into
14 chromosomes with a number of genes ranging from 5507 in P. falciparum to 7132 in P. ovale curtisi.
In addition, Plasmodium parasites contain two more genomes. A mitochondrial genome, with the
genes Cox1, Cox3 and Cytb [9], and an apicoplast genome, with genes related to the synthesis of fatty
acids [10].
One of the most ambitious goals in current research on malaria is the search for a vaccine against
the disease [11]. But, as already mentioned, the complex biology, genome, and life cycle of the
parasite, as well as its ability to evade the protective immune responses of the host, have made the
search unsuccessful. The design of malaria vaccines is very broad and varied. Currently, researchers
are working with vaccines that act at different points in the Plasmodium life cycle. On the other
hand, vaccines are being developed against a specific antigen, as well as vaccines against several
antigens at different stages of the parasite lifecycle (multi-state vaccines), or even through the use of
complete sporozoites. The use of viral vectors in heterologous prime-boost regimens represent another
interesting alternative for the development of an effective vaccine. They are all the next-generation of
malaria vaccines [12,13]. Other strategies being addressed in the fight against malaria focus on the use
of mosquito nets and repellents to try to avoid mosquito bites [14].
The analysis of malaria research is an excessively complex system to carry out with a simple
methodology. But, like other complex systems, it has a structure in scientific communities (SC), whose
approach facilitates analysis [15]. The community detection is an issue that has been under study by
the scientific community for a long time [16]. It is based on the search for substructures or communities
that best represent the network’s topological features [17]. To obtain these substructures, it is common
to use optimization techniques that combine the nodes in such a way that a certain objective function
is maximized or minimized. In this regard, the modularity function has been successfully used by the
scientific community to obtain a good definition of topologically related substructures. Modularity
was proposed by Newman [18] and measures the quality of the cluster of nodes. The higher the value,
the more precise the definition of the detected community structure. Since the invention of modularity,
constant improvements have been generated [19] giving rise to one of the best-known algorithms:
Girvan–Newman (GN), which is an algorithm based on a divisive method. This methodology has
already been used successfully in many studies [20,21] and it is a very useful tool in bibliometric
studies [22,23]. Thus, communities or clusters are generally groups of nodes that are more likely to be
connected to each other than to members of other groups or to the rest of the network [24], in particular
in bibliometric studies the scientific relations between groups of countries have been detected, or the
topics around which a certain field of research is clustered [25,26]. Communities, in complex systems,
can be defined as groups of nodes of a network, in which each node is densely connected with many
other nodes in the network. The detection of communities is based on the principle that the nodes
belonging to the same community are more likely to interact with each other. That is, they have greater
connectivity. In this article, the authors introduce the novelty of using community detection to find SC
associated with malaria research. This new approach will make it possible to establish future action
policies in order to definitively eradicate malaria.
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2. Materials and Methods
The two large scientific databases, Web of Science (WoS) and Scopus, raise the major issue of
comparison and consistency of the statistics derived from different data sources [27]. Various research
studies have assessed the superposition between both, concluding that they are similar when the
coverage since 1996 is restricted (Scopus coverage) [28,29]. Regarding the journals reported in the two
large scientific databases such as Web of Science (WoS) and Scopus, a comparative analysis shows
that the range of journals in WoS (13,605 journals) is smaller than that of Scopus (20,346 journals) [30],
and the relationships between the results obtained with both databases for the number of articles
and the number of citations obtained by countries, as well as for their rankings, are extremely strong
(R2 ≈ 0.99) [31]. Therefore, only Scopus data have been used. This methodology has been used with
success in different scientific fields [32–35].
A software has been programmed for the massive download of data from Scopus using the
developer application that allows this database. The SW can be divided into four functional blocks as
described below, see Figure 1:
1. Start Module. Which requires as input the desired search criteria, for example: TITLE (“malaria”)
OR AUTHKEY (“malaria”) OR ABS (malaria), once the criteria is selected, the time range of
the search is required and a list of SCOPUS apikeys needed to use the Scopus search service
(https://dev.elsevier.com/). The output (data files in json format containing the same data as
when searching the web, with the difference that one file is obtained for every 25 search results)
is the input for the next module of the application. It is worth highlighting the large volume of
data files generated for a search criterion such as the one mentioned above.
2. Data processing. In this second stage, each one of the results obtained in the previous phase are
analyzed, obtaining as output: a single list of the Scopus-ID of authors and a list of the DOIs of
the articles.
3. Data collection. In this stage, two threads of work are launched in parallel: one that oversees
downloading all the information of the authors for each one of the Scopus-ID of the list, generating
at least one file per author; and another that will download all the information of the articles
for each one of the DOIs of the list of papers. Therefore, a directory for authors and another for
articles where all the mentioned information will be stored is obtained as output.
4. Establishing relationships. This module, like the previous one, is computationally more expensive
and is subdivided in two: one for the analysis of the authors and the other for the analysis of
the articles.
a. Authors collection. This submodule extracts all relevant information about the authors:
H-Index, Name, Affiliation, Nation, etc. On the other hand, collaborations between authors
are sought, for this purpose each author is examined, which are their articles, extracting all
the authors from the papers of an author, establishing a bidirectional relationship between
the author and the co-authors.
b. Papers collection. In this thread we obtain information about the articles, Keys, authors,
co-authors, references to other papers, etc. For each paper we obtain a unidirectional
relationship with the paper that cites, thus generating the network of the graph.
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and exceeded completely until the 1980s. The explanation for this is found in two milestones of great 
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The Elsevier Scopus database was used to obtain information about published works on malaria.
A complete search was performed using the search query: (TITLE-ABS-AUTHKEY (malaria)).
The search range used was from 1900 to 2017. It should be noted that a different search query
can give different results. To facilitate the analysis of the data, a powerful network analysis tool, Gephi,
was used. The data extraction was carried out automatically through the implementation of a specific
software called Research Network Bot (ResNetBot) [36]. This software allows the elaboration of a
graph in which each publication on malaria is represented by a node, and the connections between two
nodes represent the existence of a citation of one article on the other. With these data, a new graphic is
constructed. This time, the nodes represent the researchers, while the relationships between the nodes
represent the collaborations in at least one publication. Data obtained through ResNetBot was refined
with the OpenRefine software (OR) (formerly Google Refine) (Google, Mountain View, CA, USA) and
organized into spreadsheets to facilitate its management. The need to use OR is justified by the fact
that authors often write slightly different keywords that identify the same concepts. In order to be
able to unify these keywords OR is used because it provides the necessary mechanisms to find and
merge written variations of the same word. E.g., “New York”, “New-York”, “new york”, etc. So, in our
research the keywords need to be refined.
3. Results
3.1. Evolution of Scientific Output
The search yielded 85,370 results, whose growth is represented in Figure 2. As can be observed,
the data show two trends. The first of them extends throughout the twentieth century, and it is
exponential, while the second one is from the year 2000 to the present, and it is linear. In the first
of the periods, the adjustment to the trend line is optimal, giving rise to a regression coefficient R2
greater than 0.9. The only data that separates from this trend line corresponds to the number of articles
published in the year 1946, which is 429. This data is abnormally high. In fact, it is not reached and
exceeded completely until the 1980s. The explanation for this is found in two milestones of great
importance in the fight against malaria that took place in that year. On the one hand, chloroquine was
recognized and established as an effective and safe antimalarial agent [37]. And, on the other hand,
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the CDC (Communicable Disease Center) was created from the Office of MCMA (Malaria Control in
War Areas), whose main objective was to fight against diseases such as malaria in the South of the
United States during the Second World War. Currently, the CDC is the main North American public
health agency and its mission is “collaborate to create the expertise, information, and tools that people,
and communities need to protect their health—through health promotion, prevention of disease, injury,
and disability—and preparedness for new health threats.” Although the initial objective of the CDC
was the control and elimination of malaria, its current role is aimed at prevention and surveillance,
because it is considered eradicated in the USA since 1951.
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Figure 2. Publications trends on Malaria from 1900–2017.
The second period that can be observed in Figure 2 is adjusted to a linear trend line. Its slope
is m = 159. That is, since 2000, each year, the average number of articles that have been published
grows by more than 150 units. This highlights the enormous interest that research around malaria has,
at present.
3.2. Authors and Countries in Malaria Research
In the 85,370 published articles on malaria in the period studied, 148,876 authors and a total
of 2,211,628 collaborations appear among them. In Table 1, the 20 most important authors can be
observed. To establish this ranking, the eigenvector centrality or eigencentrality has been taken into
account. In graph theory this is used to highlight the influence of a node in a network. Other values
that could be used to measure the importance of an author are the H-index [38], the number of
published articles, or the number of citations received by these articles. But the possibility that an
author has worked in different areas or themes could mask the result. However, a high score of the
eigenvector is directly related to the value that an author has within a network in which each author is
identified with a node, and in which the connections of each node are preferably scored with other
nodes of a high score. Figure 3A shows the 455 authors represented by nodes with an eigencentrality
value greater than 0.2, and their connections with the rest of the nodes (authors). Figure 3B shows
the 158 authors represented by nodes with an eigencentrality value greater than 0.4, and Figure 3C
shows the 31 authors represented by nodes with an eigencentrality value greater than 0.6. The very
high density of relations that exist between authors, it is possible to emphasize above all with an
eigenvector >0.2. The size of each node is proportional to the value of its eigencentrality, and the color
is representative of the country from which the author’s institutional affiliation.
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Table 1. List of authors most frequent in malaria research articles.
Author Eigencentrality Nm Nt H-Index Coauthor Cites Country
Marsh K. 1.000000 392 468 84 1748 26032 Kenya
Djimde A. 0.995692 120 123 33 1052 4656 Mali
Drakeley C. 0.965505 284 294 58 1781 11934 United Kingdom
Doumbo O. 0.957462 389 424 56 1921 13477 Mali
Nosten F. 0.829049 512 568 78 2160 23142 Thailand
Ouédraogo J. 0.816295 119 147 29 962 3137 Burkina Faso
Borrmann S. 0.816208 87 87 31 676 3818 Kenya
Mueller I. 0.808423 276 289 40 1224 5830 Australia
Price R. 0.786288 227 241 54 1150 9966 United Kingdom
Hien T. 0.786204 246 271 70 1763 19209 Viet Nam
Plowe C. 0.749014 179 187 55 1216 10896 United States
D’Alessandro U. 0.746263 298 315 43 1483 7497 United Kingdom
White N. 0.726106 897 1146 114 3134 52466 Thailand
Mayxay M. 0.703699 113 117 32 866 3941 Laos
Bousema T. 0.702141 136 165 34 827 4205 United Kingdom
Kwiatkowski D. 0.690173 270 335 63 2069 17684 United Kingdom
Dondorp A. 0.685832 285 312 52 1367 10554 Netherlands
Ogutu B. 0.681686 130 139 27 1017 3031 Kenya
Fanello C. 0.680121 42 43 21 508 2648 Thailand
Greenwood B. 0.676612 458 893 77 1848 23579 United Kingdom
Nm, number of articles published on malaria; Nt, number of total articles published, including those whose main
topic is not malaria; Coauthor, number of co-authors that appear in articles published on malaria; Cites, number of
citations that have received articles published on malaria.
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and their con ections with the rest of the nodes (authors). (A) Greater than 0.2; (B) Greater than 0.4;
(C) Greater than 0.6.
Figure 3 attempts to represent the relationship between authors from different countries, as well
as their relevance. Therefore, a visualization (by color) of the authors from the different countries is
sought, obtaining a general idea of which countries prevail over others, as well as the relevance of the
main authors from one country versus authors from other countries. Due to the large number of nodes
(authors) it is not possible to indicate their names.
As can be observed in Table 1, the first 20 authors in malaria research belong to ten different
countries. These can be considered in two groups. On the one hand, the African (Kenya, Mali and
Burkina Faso) and Asians (Thailand, Viet Nam and Laos) countries, of great importance for the
number of estimated cases and deaths produced by malaria; and, on the other hand, the European
(United Kingdom, and Netherlands), American (USA) and Australian (Australia) countries, of great
importance for the number of articles published. Figure 4 shows the countries with the highest number
of cases estimated by the World Health Organization in the period 2010–2016 (Figure 4A), which
have presented a greater number of deaths estimated in that same period (Figure 4B), and those
that have published the most articles in 1900–2017 (Figure 4C). Burkina Faso and Mali are among
the five countries with the highest number of deaths, while the United States and the United
Kingdom are the two countries whose institutions publish the most articles on malaria. For this
reason, it is not surprising that the main researchers working in these countries are those with the
highest eigencentrality.
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3.3. Communities Detection
From 85,370 published articles, 714,979 citations were counted—the citations to nodes of topics
other than malaria were not included. On the other hand, 149,143 keywords defined by the authors
appear in these articles. Both data allow us, using genetic algorithms, to establish a series of thematic
SC, of which, the most frequent are represented in Table 2. In the table only appear SC composed of at
least 1% of the total of 85,370 articles published. To supplement Table 2, Figure 5 has been carried out.
The information that codifies Figure 5 has to do with the relative size of one community in front of the
other as well as the proximity of certain communities to each other, depending on how close the nodes
in the graph are.
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Table 2. Main scientific communities in malaria research.
Comm. % Community Topic Keyword 1 Keyword 2 Keyword 3 Keyword 4 Keyword 5
#1 5.64 Mosquitoes and insecticides An. gambiae Anopheles P. falciparum Malaria vector Vector control
#2 5.40 Drug resistance P. falciparum Artemisinin Chloroquine Drug resistance Antimalarial
#3 3.28 Apicomplexa P. falciparum Plasmodium P. berghei Apicoplast Erythrocyte
#4 3.16 Severe malaria P. falciparum Cerebral malaria Cytokines Severe malaria Children
#5 3.13 Malaria diagnosis P. falciparum Diagnosis Microscopy Plasmodium P. vivax
#6 3.05 Vaccines P. falciparum Vaccine Plasmodium P. vivax Malaria vaccine
#7 1.77 Pregnancy and VIH Pregnancy P. falciparum HIV Placenta Anemia
#8 1.44 Plasmodium vivax P. vivax P. falciparum Primaquine Chloroquine Thrombocytopenia
#9 1.35 Mosquitoes and immunity Mosquito P. falciparum Plasmodium An. gambiae Anopheles
#10 1.31 Travel and drugs P. falciparum Mefloquine Chemoprophylaxis Travel Prophylaxis
#11 1.03 Glucose-6-phosphate dehydrogenase P. falciparum G6PD deficiency Oxidative stress Thalassemia Sickle cell disease
Comm., community; An. Anopheles; P. Plasmodium. %, percentage of articles belonging to a community with respect to the total number of published articles in malaria.
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Keywords 1 to 5 appear ordered according to their appearance frequency in each SC,
after eliminating malaria as keyword, since it appears in first place in all detected communities,
but its presence does not contribute anything to the analysis. In Figure 5, the 11 main SC appear
highlighted using different colors.
Communities #1 and #2 had the highest proportion of published articles, and each of them
is focused on the two main fields of action that currently exist against malaria: the fight against
mosquitoes and drug resistance. Today, it is demonstrated that the most effective way to reduce
severe malaria and the number of deaths caused by the disease, in endemic regions, is the use of
insecticide-treated bed nets (ITNs) [39,40]. The use of ITNs reduces both the number of mosquitoes
and their length of life, producing a double protection effect in the affected regions. The only class
of insecticides allowed in the ITNs are the pyrethroids, due to the low toxicity effect in human
health, and to their slow decomposition. Therefore, it is essential to find new systems that prevent
the transmission of malaria, as well as new insecticides that repel mosquitoes from areas of human
concentration. The second major concern of the international scientific community in the fight against
malaria is the presence of drug resistance in Plasmodium. Over time, as new antimalarial drugs have
been introduced, the parasite has become resistant to them. First, it happened with chloroquine
and other similar 4-aminoquinolines. Then, resistance to sulfadoxine-pyrimethamine. And, more
recently, cases of parasites resistant to drugs derived from artemisinin have also been discovered [41].
So, the long-term success of this strategy will depend to a large extent on the control over the ways
that the parasite develops drug resistance. Therefore, it is a priority to approach this problem from
different perspectives. It will have to be done both from the pharmacological point of view, with the
use of drug combinations with different formulations, and from the strategic point of view, in terms of
health infrastructure.
The following SC #3, #4, #5, and #6 are focused on the study of apicomplexa, severe malaria,
diagnosis and vaccines, respectively. Of them, the research on a vaccine that ends the disease arouses
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the greatest interest [42]. There is currently no effective malaria vaccine, but there are three lines
of action targeting key points in the life cycle of the malaria parasite: the anti-infection approach
(pre-erythrocytic vaccines), blood-stage vaccines, and transmission-blocking vaccines, interrupting the
spread of infection. It is likely that the definitive solution comes from the combination of several of
these approaches. At the moment, one pre-erythrocytic candidate, the RTS,S vaccine [43], is going to
be administered in a pilot implementation.
The last five communities of Table 2—SC #7, #8, #9, #10, and #11—involve topics such as pregnancy
and VIH, Plasmodium vivax, mosquitoes and immunity, travel and drugs, and glucose-6-phosphate
dehydrogenase. Of these, research in P. vivax, a highly prevalent parasite in most affected areas except
Africa, is becoming very important. Although more severe cases of malaria associated exclusively with
P. vivax are detected, a large number of mixed infections of P. falciparum and P. vivax are diagnosed
in patients living in areas where both species are prevalent. For the rest, it should be borne in mind
that pregnant women and their unborn children are particularly vulnerable to the disease, that every
year there are detected thousands of cases of malaria in travelers in countries where the disease
was eliminated, and there is a concern about the use of primaquine in people with a deficiency in
glucose-6-phosphate dehydrogenase (G6PD), as it can cause severe hemolysis. All these aspects focus
the research of a large number of work teams throughout the world.
4. Discussion
4.1. Findings
Eradication of malaria is on the global health agenda. Therefore, now is the time to ask ourselves
at what point malaria stands, how much we know about the human disease, the parasite and the
mosquito vectors [44,45] and take the correct directions for malaria control and elimination.
After more than a century of research on malaria, the number of articles published on it
is enormous. There are almost 100,000 records, with different approaches and an accumulated
knowledge acquisition that makes necessary an analysis of the data based on algorithms that facilitate
its interpretation.
After analyzing about 150,000 authors and the more than two million relationships established
between them, we have been able to establish a parameter that measures the role played by each author
in the complex network of researchers who published on malaria research. So, we have seen that
authors like Kevin Marsh (Kenya Medical Research Institute, Kenya), Abdoulaye A. Djimde (University
of Sciences, Department of Epidemiology of Parasitic Diseases, Mali), Chris J. Drakeley (London School
of Hygiene & Tropical Medicine, United Kingdom), or Ogobara K. Doumbo (University of Bamako
Faculty of Medicine, Mali), occupy a position of enormous relevance. The topics of their research
work range from the characterization of malaria as a severe disease, for Marsh et al., to the control
of transmission, for Drakeley et al., or the study of drug resistance, for Djimde et al. But all of them
have in common a very high consideration on the part of their colleagues and an extensive network of
collaboration that favor the advance of the malaria knowledge.
A second aspect that we have considered is the set of keywords with which the authors delimit
and define the scope of their research. The analysis of the 150,000 keywords appeared in the articles
on malaria has allowed us to detect, through the use of an iterative algorithm, up to 11 communities.
The analysis of these communities allows us to draw a map about worldwide malaria research. Thus,
we have seen that most research efforts are focused on drug resistance and control of the mosquito
vector species. Also, of great importance, especially in recent years, the research focused on vaccine
development or knowledge of parasites other than Plasmodium falciparum, such as P. vivax.
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4.2. Limitations
In such a large data analysis, as that carried out for all published works on malaria, an additional
problem is that of the dense data representation, it has been found that representation values as a
function of eigenvector value >0.2 is appropriate.
4.3. Future Work
After eradicating malaria from Europe, North America, the Caribbean, and some countries
of South-Central America and Asia, the time has come to consider removing it from the countries
where, at present, malaria is a true public health problem, such as the sub-Saharan Africa countries.
But, for this, the combination of all the tools with which science counts nowadays will be necessary.
The collaborative networks between countries and scientists of notable importance will have to be
strengthened, so that, the confluence of their knowledge finds the end to malaria. No one is thinking
that a simple approach will eliminate malaria in Africa or other areas. It will not be just the fight
against the mosquito, or the administration of a vaccine. It will be the union of all efforts in the search
for a global strategy, also at a political, financial, educational, and social level.
5. Conclusions
These results allow us to have a global view of the state of world malaria research. This is the
first time that a manuscript studies the relationship between the work of the most important groups
in this field. For the first time, the lines of research of greatest interest to the international scientific
community have been drawn, and the multilateral relations that are taking place between the different
scientific communities involved in this research have been established. Furthermore, this study shows
that the role of each scientist, each institution or each country in the fight to eradicate malaria is unique
and plays a unique role within the network of which it forms a part.
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